Keros Therapeutics Inc (KROS)

Other Income/Expenses (Net)

$2.23M

Quarterly · Period ending: · USD

KROS logo

KROS Other Income/Expenses (Net)

Latest reported$2.23M
KROS Quarterly Other Income/Expenses (Net) (-$325.00K → $2.23M)
High-resolution chart · PNG

KROS other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
2,227,000
2,169,000
4,295,000
6,680,000
6,899,000
6,454,000
7,528,000
5,701,000
5,182,000
5,369,000
6,212,000
3,840,000
3,832,000
3,065,000
2,242,000
4,467,000
3,462,000
-60,000
-75,000
-138,000
-81,000
-66,000
2,615,000
-88,000
157,000
-1,560,000
-23,000
-1,223,000
-202,000
-325,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.